Loading...
Intracerebroventricularly-administered 1-methyl-4-phenylpyridinium ion and brain-derived neurotrophic factor affect catecholaminergic nerve terminals and neurogenesis in the hippocampus, striatum and substantia nigra
Parkinson's disease is a progressive neurological disease characterized by the degeneration of dopaminergic neurons in the substantia nigra. A highly similar pattern of neurodegeneration can be induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-methyl-4-phenylpyridinium ion (MP...
Na minha lista:
Main Authors: | , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Serier: | Neural Regeneration Research |
Fag: | |
Online adgang: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=4;spage=717;epage=726;aulast=Chen |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|